Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting

Hypertension Research

Volumn 36, Issue 9, 2013, Pages 807-823

  Kim, Yon Su ^a   Kim, Han Soo ^b   Oh, Ha Young ^c   Lee, Moon Kyu ^c   Kim, Cheol Ho ^d   Kim, Yong Soo ^e   Wu, David ^e   Johnson Levonas, Amy O ^e   Oh, Byung Hee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b 21st Century Hospital   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

hypertension; Korean; microalbuminuria; prevalence; primary care

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COMORBIDITY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GENERAL HOSPITAL; HUMAN; INDEPENDENT VARIABLE; KIDNEY DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION COMPLIANCE; MICROALBUMINURIA; OBESITY; PREDICTOR VARIABLE; PREVALENCE; PRIMARY MEDICAL CARE; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84883875917     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.44     Document Type: Article

References (56)

1. Cerasola G, Cottone S, Mule G. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor. J Hypertens 2010; 28: 2357-2369.
2. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 550-555. (Pubitemid 12089232)
3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-1432. (Pubitemid 12123979)
4. Haneda M, Kikkawa R, Togawa M, Koya D, Kajiwara N, Uzu T, Shigeta Y. High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus. J Diabetes Complications 1992; 6: 181-185. (Pubitemid 23129151)
5. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901-906.
6. Forman JP, Brenner BM. 'Hypertension' and 'microalbuminuria': the bell tolls for thee. Kidney Int 2006; 69: 22-28. (Pubitemid 43117734)
7. Choi HS, Sung KC, Lee KB. The prevalence and risk factors of microalbuminuria in normoglycemic, normotensive adults. Clin Nephrol 2006; 65: 256-261.
8. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Takasaki S, Kubota I. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 2006; 70: 751-756. (Pubitemid 44215351)
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
11. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707-716.
12. Romundstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trondelag Health Study (HUNT), Norway. Circulation 2003; 108: 2783-2789. (Pubitemid 37498981)
13. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2: 259-261. (Pubitemid 19087206)
14. Gerber LM, Shmukler C, Alderman MH. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch Intern Med 1992; 152: 373-377.
15. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; 1: 1190-1192.
16. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Goteborg, Sweden. J Hypertens 1985; 3: 167-176. (Pubitemid 15117571)
17. Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H. Apparent prevalence of curable hypertension in the hypertension detection and follow-up program. Arch Intern Med 1985; 145: 424-427. (Pubitemid 15140733)
18. Bulpitt CJ, Beevers DG, Butler A, Coles EC, Hunt D, Munro-Faure AD, Newson RB, O'Riordan PW, Petrie JC, Rajagopalan B. The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP). J Hypertens 1986; 4: 93-99. (Pubitemid 16129690)
19. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108: 1347-1352. (Pubitemid 15210767)
20. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 2: 530-533.
21. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431. (Pubitemid 28405191)
22. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223. (Pubitemid 40138015)
23. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063. (Pubitemid 43924271)
24. Shi HL, Fang JC, Zhu XX. Prevalence of diabetes mellitus and associated risk factors in an adult urban population in Shanghai. Diabetes Metab 1998; 24: 539-542. (Pubitemid 29048423)
25. Gozzoli V, Palmer AJ, Brandt A, Spinas GA. Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting. Swiss Med Wkly 2001; 131: 303-310. (Pubitemid 32601560)
26. Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol 1992; 37: 345-350.
27. Yamada T, Komatsu M, Komiya I, Miyahara Y, Shima Y, Matsuzaki M, Ishikawa Y, Mita R, Fujiwara M, Furusato N, Nishi K, Aizawa T. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study. Diabetes Care 2005; 28: 2733-2738. (Pubitemid 43951168)
28. Buranakitjaroen P, Deerochanawong C, Bunnag P. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand. J Med Assoc Thai 2005; 88: 1624-1629. (Pubitemid 44698979)
29. DU J, Pan CY. [A survey of microalbuminuria prevalence in hypertensive type 2 diabetic patients in mainland China]. Zhonghua Nei Ke Za Zhi 2007; 46: 184-188.
30. Guan MP, Li CZ, Xue YM, Shen J, Gao F, Luo XR. [Prevalence of microalbuminuria in type 2 diabetic patients with hypertension]. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 234-235.
31. Kong NC, Chia YC, Khalid BA, Juwita S, Samiah Yasmin AK, Yap LY, Norlaila M, Menon J, Tan C, Fung YK. Microalbuminuria prevalence study in hypertensive type 2 diabetic patients in Malaysia. Med J Malaysia 2006; 61: 457-465.
32. Sja'bani M, Asdie AH, Widayati K, Subroto Y, Kariadi SH, Arifin AY, Adhiarta IG, Permana H, Hendromartono T A, Adi S, Wibisono S, Murtiwi S. Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes in Indonesia. Acta Med Indones 2005; 37: 199-204.
33. Weir MR. Albuminuria predicting outcome in diabetes: incidence of microalbuminuria in Asia-Pacific Rim. Kidney Int Suppl 2004; 92: S38-S39. (Pubitemid 43361427)
34. Wu AY, Tan CB, Eng PH, Tan KT, Lim SC, Tan EK. Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes mellitus in Singapore. Singapore Med J 2006; 47: 315-320.
35. Yeung VT, Lee KF, Chan SH, Ho LF, Leung SK, Wong HY. MicroAlbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong. Hong Kong Med J 2006; 12: 185-190. (Pubitemid 43925931)
36. Chan GC. Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they managed according to guidelines? Singapore Med J 2005; 46: 127-131.
37. Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 1998; 21: 530-534. (Pubitemid 28172929)
38. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
39. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, van Gilst WH, De Zeeuw D, De Jong PE. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526. (Pubitemid 32823860)
40. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28: 156-162.
41. Bohm M, Thoenes M, Danchin N, Bramlage P, La Puerta P, Volpe M. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens 2007; 25: 2317-2324. (Pubitemid 47537927)
42. Cerasola G, Mule G, Cottone S, Nardi E, Cusimano P. Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study. J Nephrol 2008; 21: 368-373.
43. Cerasola G, Mule G, Nardi E, Cusimano P, Palermo A, Arsena R, Guarneri M, Geraci C, Cottone S. Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study. J Hum Hypertens 2010; 24: 44-50.
44. Kim CH, Kim HK, Park JY, Park HS, Hong SK, Park SW, Lee KU. Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea. Diabetes Res Clin Pract 1998; 40: 191-199. (Pubitemid 28332881)
45. National Heart, Lung, and Blood Institute. JNC 7 Express: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National Institute of Health, Bethesda, MD, 2003.
46. Micral Test: an Accu-Check product 2008, Indianapolis, In, Roche Diagnostics Ltd.
47. Annemans L, Demarteau N, Hu S, Lee TJ, Morad Z, Supaporn T, Yang WC, Palmer AJ. An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy. Value Health 2008; 11: 354-364. (Pubitemid 351712966)
48. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003; 42: 617-622. (Pubitemid 37187362)
49. Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chim Acta 1995; 243: 95-99.
50. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997; 20: 516-519. (Pubitemid 27143407)
51. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975. (Pubitemid 41170264)
52. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426. (Pubitemid 32681484)
53. Hillege HL, Fidler V, Diercks GF, van Gilst WH, De Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, De Jong PE. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
54. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35. (Pubitemid 38880131)
55. Cerasola G, Cottone S, Mule G, Nardi E, Mangano MT, Andronico G, Contorno A, Li VM, Galione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N, Riccobene R. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 14: 915-920. (Pubitemid 26237214)
56. Hsu CC, Brancati FL, Astor BC, Kao WH, Steffes MW, Folsom AR, Coresh J. Blood pressure, atherosclerosis, and albuminuria in 10 113 participants in the atherosclerosis risk in communities study. J Hypertens 2009; 27: 397-409.